Bruce C. Cozadd
2019
Compensation breakdown
| Non-Equity Incentive Plan | $1,304,500 |
|---|---|
| Option Awards | $5,379,925 |
| Salary | $1,014,415 |
| Stock Awards | $7,001,495 |
| Other | $13,302 |
| Total | $14,713,637 |
Cozadd received $7M in stock awards, accounting for 48% of the total pay in 2019.
Cozadd also received $1.3M in non-equity incentive plan, $5.4M in option awards, $1M in salary and $13.3K in other compensation.
Rankings
In 2019, Bruce C. Cozadd's compensation ranked 344th out of 13,971 executives tracked by ExecPay. In other words, Cozadd earned more than 97.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 344 out of 13,971 | 98th |
Division Manufacturing | 122 out of 5,701 | 98th |
Major group Chemicals And Allied Products | 34 out of 2,200 | 99th |
Industry group Drugs | 27 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 23 out of 1,398 | 98th |
Pay ratio
| Bruce C. Cozadd's Pay | $14,713,637 |
|---|---|
| Median Employee's Pay | $214,881 |
| Pay Ratio | 68to 1 |
In 2019, the annual total compensation of Bruce C. Cozadd was $14,713,637.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $214,881.
The ratio of Bruce C. Cozadd's pay to the pay of median employee was therefore 68 to one.
Cozadd's colleagues
We found six more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2019.
2019
Daniel Swisher
Jazz Pharmaceuticals
Chief Operating Officer
2019
Robert Iannone
Jazz Pharmaceuticals
Executive Vice President, Research and Development
2019
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2019
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
2019
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2019
Neena Patil
Jazz Pharmaceuticals
Senior Vice President and GC
News
June 10, 2022
June 11, 2021
June 12, 2020
June 14, 2019